Stefan Ewert, Associate Director, Novartis Pharma AG, Basel, Switzerland
We will show adaptations to library design and planning strategies exploiting the full potential of deep sequencing analysis of phage selection output pools to identify specific and high affine antibodies without conventional screening.
